VYNE Therapeutics Cash from Financing (TTM) Insights

VYNE Therapeutics Inc (VYNE)

2.58 -0.19 (-6.86%) USD | NASDAQ | Apr 15, 16:00

Cash from Financing (TTM) Chart

Historical Cash from Financing (TTM) Data

View and export this data back to 2018. Upgrade now.

Date	Value
December 31, 2023	82.39M
September 30, 2023	-0.061M
June 30, 2023	-0.04M
March 31, 2023	-0.096M
December 31, 2022	1.653M
September 30, 2022	1.407M
June 30, 2022	-32.13M
March 31, 2022	-32.19M
December 31, 2021	39.78M
September 30, 2021	47.80M
June 30, 2021	81.44M
March 31, 2021	135.17M

Date	Value
December 31, 2020	61.81M
September 30, 2020	53.70M
June 30, 2020	53.79M
March 31, 2020	2.119M
December 31, 2019	4.994M
September 30, 2019	5.123M
June 30, 2019	5.439M
March 31, 2019	3.539M
December 31, 2018	125.91M
September 30, 2018	125.04M
June 30, 2018	174.91M

Cash From Financing Definition

Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.

Read full definition.

Cash from Financing (TTM) Range, Past 5 Years

-32.19M

Minimum

Mar 2022

135.17M

Maximum

Mar 2021

26.95M

Average

5.123M

Median

Sep 2019

Cash from Financing (TTM) Benchmarks